{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:14:58Z","timestamp":1792642498435,"version":"4.5.0"},"reference-count":97,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Differentiation Syndrome (DS) has been identified in a subset of patients undergoing treatment with novel classes of differentiating therapies for acute myeloid leukemia (AML) such as IDH and FLT3 inhibitors. While DS is a well\u2010known treatment\u2010related complication in acute promyelocytic leukemia (APL), efforts are still ongoing to standardize diagnostic and treatment parameters for DS in AML. Though the rates of incidence vary, many of the signs and symptoms of DS are common between APL and AML. So, DS can lead to fatal complications in AML, but prompt management is usually effective and rarely necessitates interruption or discontinuation of AML therapy.<\/jats:p>","DOI":"10.1002\/ajh.26142","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:36:20Z","timestamp":1614166580000},"page":"735-746","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Differentiation syndrome with lower\u2010intensity treatments for acute myeloid leukemia"],"prefix":"10.1002","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4907-6447","authenticated-orcid":false,"given":"Amir T.","family":"Fathi","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital Cancer Center  Boston Massachusetts USA"},{"name":"Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center  New York New York USA"},{"name":"Weill Cornell Medical College  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-0390","authenticated-orcid":false,"given":"Courtney D.","family":"DiNardo","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-6982","authenticated-orcid":false,"given":"Mark J.","family":"Levis","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-5593","authenticated-orcid":false,"given":"Pau","family":"Montesinos","sequence":"additional","affiliation":[{"name":"Hospital Universitari I Politecnic La Fe  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8126-4942","authenticated-orcid":false,"given":"St\u00e9phane","family":"de Botton","sequence":"additional","affiliation":[{"name":"Gustave Roussy  Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568009620666200424145622"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0876"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-017-0363-4"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.04.006"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0834"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.4695"},{"issue":"1","key":"e_1_2_9_9_1","first-page":"e2011048","article-title":"Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors","volume":"30","author":"Rego EM","year":"2008","journal-title":"Rev Bras Hematol Hemoter"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020485"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.059"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.8.2712"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-4-292"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018029496"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2011.8"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-216457"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v6.i8.583"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.5045\/br.2013.48.4.250"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91415-5"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/35901"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.14807"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80044-F"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.10.002"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.567.567"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5416"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e10-05-0449"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000448160"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1717"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.103"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-01-894980"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0589-3"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-512640"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168617"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.048"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.04.011"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.09.017"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402807"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716984"},{"issue":"1","key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"Abstract 288","DOI":"10.1182\/blood-2018-99-117426","article-title":"Incidence of differentiation syndrome with ivosidenib (IVO) and enasidenib (ENA) for treatment of patients with relapsed or refractory (R\/R) isocitrate dehydrogenase (IDH)1\u2010 or IDH2\u2010mutated acute myeloid leukemia (AML): a systematic analysis by the U.S. Food and Drug Administration (FDA)","volume":"132","author":"Norsworthy KJ","year":"2018","journal-title":"Blood"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.061"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12598"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052242"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478172"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.6121"},{"key":"e_1_2_9_45_1","unstructured":"LarsonRA BagR.Differentiation syndrome associated with treatment of acute leukemia.UpToDate2019.https:\/\/www.uptodate.com\/contents\/differentiation-syndrome-associated-with-treatment-of-acute-leukemia. Accessed September 23 2019."},{"key":"e_1_2_9_46_1","unstructured":"TIBSOVO\u00ae (ivosidenib) Prescribing Information.Agios Pharmaceuticals Inc. Cambridge MA. Rev 07\/2018. 2018. Accessed March 13 2019."},{"key":"e_1_2_9_47_1","unstructured":"IDHIFA\u00ae (enasidenib) Prescribing Information.Celgene Corporation Summit NJ. Rev 08\/17."},{"key":"e_1_2_9_48_1","unstructured":"Xospata\u00ae (gilteritinib) Prescribing Information.Astellas Pharma N IL. Rev 05\/2019."},{"issue":"8","key":"e_1_2_9_49_1","first-page":"2138","article-title":"Clinical pharmacology of oral all\u2010trans retinoic acid in patients with acute promyelocytic leukemia","volume":"52","author":"Muindi JR","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-006-0288-4"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.43.30527"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010120200"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.2208"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.217406.113"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1231677"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-402545"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01423"},{"issue":"1","key":"e_1_2_9_60_1","first-page":"231","article-title":"Olutasidenib (FT\u20102102), an IDH1m inhibitor as a single agent or in combination with Azacitidine, induces deep clinical responses with mutation clearance in patients with acute myeloid leukemia treated in a phase 1 dose escalation and expansion study","volume":"134","author":"Cortes JE","year":"2019","journal-title":"Blood"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-869008"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110449"},{"issue":"1","key":"e_1_2_9_63_1","first-page":"643","article-title":"Enasidenib plus Azacitidine significantly improves complete remission and overall response compared with Azacitidine alone in patients with newly diagnosed acute myeloid leukemia (AML) with Isocitrate dehydrogenase 2 (IDH2) mutations: interim phase II results from an ongoing, randomized study","volume":"134","author":"D\u00f6hner H","year":"2019","journal-title":"Blood"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-143265"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1159\/000507613"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106406"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007233"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.236992"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0996-5"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1073.1073"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.7b00342"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00509"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061115"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.2.459"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0357-9"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620714532123"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12841"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30150-0"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222034"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12599"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614359"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902688"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000775"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.320"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V104.11.4528.4528"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480228"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.388.388"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.346"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0749-y"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-818948"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-684225"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2020.05.013"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0811-9"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.11.066"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0892-z"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000559320.71687.58"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03250"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134310"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.26142","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T01:30:41Z","timestamp":1693099841000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.26142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1002\/ajh.26142"],"URL":"https:\/\/doi.org\/10.1002\/ajh.26142","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"2020-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}